Brief: Tianjin Teda Biomedical Engineering Co Group Sees To Incur FY Loss Attributable
13/03/2019 12:56
March 13 (Reuters) - Tianjin TEDA Biomedical Engineering Co
Ltd 8189.HK :
* GROUP IS EXPECTED TO INCUR A LOSS ATTRIBUTABLE TO
SHAREHOLDERS
FOR YEAR ENDED 31 DECEMBER 2018
* EXPECTED RESULT DUE TO QUANTITATIVE EEG DETECTION BUSINESS
NOT
DEVELOPED AS EXPECTED DUE TO OPERATING ENVIRONMENT
Source text for Eikon: ID:nHKS63Nbj0
Further company coverage: 8189.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tianjin Teda Biomedical Engineering Co
See all newsBrief: Tianjin Teda Biomedical Engineering Appoints Lynn Li As Joint CEO, Re-Designates Sun Li As Joint CEO
Brief: Tianjin Teda Biomedical Engineering Signs AI Healthcare Cooperation Agreement
Brief: Tianjin Teda Biomedical Engineering Says Unit Enters Strategic Cooperation
Brief: Tianjin Teda Biomedical Engineering Says Zhongtai International Securities To Procure Placees
Brief: Tianjin Teda Biomedical Engineering Says Re-Designation Of He Xin To Non-Executive Director